STERILIZATION SERVICES MARKET ANALYSIS

Sterilization Services Market, By Method (Ethylene Oxide (ETO) Sterilization, Gamma Sterilization, Steam Sterilization, Electron Beam, Radiation Sterilization, and Other Methods), By Business Type (Contract Sterilization Services and Sterilization Validation Services), By End User (Medical Device Companies, Hospitals and Clinics, Pharmaceutical and Biotechnology Industry, and Other End Users), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Apr 2023
Code : CMI5657
Pages :157
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Global Sterilization Services Market: Regional Insights

Based on geography, the global sterilization services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the increasing prevalence of chronic disease, increase in burden of hospital acquired infections, and rise in use of sterilization agents and equipment in the region. For instance, HAIs (hospital acquired infections) are a growing threat to patient safety in the United States. According to the Centers for Disease Control and Prevention (CDC), every year, over 1.7 million hospitalized patients acquire HCAIs while being treated for other health issues and more than 98,000 patients (one in 17) die due to these infections.

Europe and Asia Pacific are also expected to witness significant growth in the global sterilization services market owing to the rise in hospital acquired infections, rise in burden of chronic disease, and increase in demand for sterilization agents and equipment in these regions. For instance, such high burden of chronic diseases leads to an increased number of medical procedures which require medical equipment. According to the Indian Council of Medical Research (ICMR), India’s cancer cases could increase by 12% in the next five years, with 1.5 million people projected to suffer from the non-communicable disease by 2025, up from 1.39 million in 2020.

North America: U.S. and Canada

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa